BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16687448)

  • 1. Negative regulation of Hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase.
    Koide T; Hayata T; Cho KW
    Development; 2006 Jun; 133(12):2395-405. PubMed ID: 16687448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late gestational lung hypoplasia in a mouse model of the Smith-Lemli-Opitz syndrome.
    Yu H; Wessels A; Chen J; Phelps AL; Oatis J; Tint GS; Patel SB
    BMC Dev Biol; 2004 Feb; 4():1. PubMed ID: 15005800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis.
    Cooper MK; Wassif CA; Krakowiak PA; Taipale J; Gong R; Kelley RI; Porter FD; Beachy PA
    Nat Genet; 2003 Apr; 33(4):508-13. PubMed ID: 12652302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of ventral cell populations in the developing brain in a rat model of the Smith-Lemli-Opitz syndrome.
    Gofflot F; Kolf-Clauw M; Clotman F; Roux C; Picard JJ
    Am J Med Genet; 1999 Nov; 87(3):207-16. PubMed ID: 10564872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical and microarray analyses of a mouse model for the smith-lemli-opitz syndrome.
    Waage-Baudet H; Dunty WC; Dehart DB; Hiller S; Sulik KK
    Dev Neurosci; 2005; 27(6):378-96. PubMed ID: 16280635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cholesterol levels impair Smoothened activation in Smith-Lemli-Opitz syndrome.
    Blassberg R; Macrae JI; Briscoe J; Jacob J
    Hum Mol Genet; 2016 Feb; 25(4):693-705. PubMed ID: 26685159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of nine novel DHCR7 missense mutations in patients with Smith-Lemli-Opitz syndrome (SLOS).
    Waye JS; Krakowiak PA; Wassif CA; Sterner AL; Eng B; Nakamura LM; Nowaczyk MJ; Porter FD
    Hum Mutat; 2005 Jul; 26(1):59. PubMed ID: 15954111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol homeostasis in development: the role of Xenopus 7-dehydrocholesterol reductase (Xdhcr7) in neural development.
    Tadjuidje E; Hollemann T
    Dev Dyn; 2006 Aug; 235(8):2095-110. PubMed ID: 16752377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome.
    Correa-Cerro LS; Porter FD
    Mol Genet Metab; 2005 Feb; 84(2):112-26. PubMed ID: 15670717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
    Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
    Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome.
    Waterham HR; Wanders RJ
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):340-56. PubMed ID: 11111101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiency.
    Jiang XS; Backlund PS; Wassif CA; Yergey AL; Porter FD
    Mol Cell Proteomics; 2010 Jul; 9(7):1461-75. PubMed ID: 20305089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smith-Lemli-Opitz syndrome and the DHCR7 gene.
    Jira PE; Waterham HR; Wanders RJ; Smeitink JA; Sengers RC; Wevers RA
    Ann Hum Genet; 2003 May; 67(Pt 3):269-80. PubMed ID: 12914579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy.
    Correa-Cerro LS; Wassif CA; Kratz L; Miller GF; Munasinghe JP; Grinberg A; Fliesler SJ; Porter FD
    Hum Mol Genet; 2006 Mar; 15(6):839-51. PubMed ID: 16446309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHCR7: A vital enzyme switch between cholesterol and vitamin D production.
    Prabhu AV; Luu W; Li D; Sharpe LJ; Brown AJ
    Prog Lipid Res; 2016 Oct; 64():138-151. PubMed ID: 27697512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photosensitive Smith-Lemli-Opitz syndrome is not caused by a single gene mutation: analysis of the gene encoding 7-dehydrocholesterol reductase in five U.K. families.
    Anstey AV; Azurdia RM; Rhodes LE; Pearse AD; Bowden PE
    Br J Dermatol; 2005 Oct; 153(4):774-9. PubMed ID: 16181459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
    Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
    Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management.
    Porter FD
    Eur J Hum Genet; 2008 May; 16(5):535-41. PubMed ID: 18285838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutation analysis.
    Waye JS; Eng B; Nowaczyk MJ
    Prenat Diagn; 2007 Jul; 27(7):638-40. PubMed ID: 17441222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A direct requirement for Hedgehog signaling for normal specification of all ventral progenitor domains in the presumptive mammalian spinal cord.
    Wijgerde M; McMahon JA; Rule M; McMahon AP
    Genes Dev; 2002 Nov; 16(22):2849-64. PubMed ID: 12435628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.